ANTIVIRAL DRUGS IN PEDIATRICS

被引：9

作者：

BALFOUR, HH

ENGLUND, JA

机构：

[1] UNIV MINNESOTA,HLTH SCI CTR,DEPT PEDIAT,MINNEAPOLIS,MN 55455

[2] TEXAS MED CTR,BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77025

[3] TEXAS MED CTR,BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77025

来源：

AMERICAN JOURNAL OF DISEASES OF CHILDREN | 1989年 / 143卷 / 11期

关键词：

D O I：

10.1001/archpedi.1989.02150230065025

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：1307 / 1316

页数：10

共 87 条

[1] THE TREATMENT OF CHRONIC TYPE-B VIRAL-HEPATITIS [J].

AACH, RD .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) :89-91

[2] EFFECT OF ACYCLOVIR ON INFECTIOUS-MONONUCLEOSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

ANDERSSON, J ;

BRITTON, S ;

ERNBERG, I ;

ANDERSSON, U ;

HENLE, W ;

SKOLDENBERG, B ;

TISELL, A .

JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (02) :283-290

[3] ACYCLOVIR HALTS PROGRESSION OF HERPES-ZOSTER IN IMMUNOCOMPROMISED PATIENTS [J].

BALFOUR, HH ;

BEAN, B ;

LASKIN, OL ;

AMBINDER, RF ;

MEYERS, JD ;

WADE, JC ;

ZAIA, JA ;

AEPPLI, D ;

KIRK, LE ;

SEGRETI, AC ;

KEENEY, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1448-1453

[4] A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].

BALFOUR, HH ;

CHACE, BA ;

STAPLETON, JT ;

SIMMONS, RL ;

FRYD, DS .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387

[5] HERPESVIRUS ENCEPHALITIS FOLLOWING HERPES KERATITIS [J].

BALFOUR, HH ;

LOCKMAN, LA .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1973, 126 (03) :357-359

[6]

BALFOUR HH, 1988, ANTIMICROBIAL AGENTS, V3, P345

[7]

Banks G, 1984, CLIN APPLICATIONS RI, P203

[8]

BAUER DJ, 1960, LANCET, V1, P1110

[9]

BAUER DJ, 1963, LANCET, V2, P494

[10]

BEAN B, 1982, LANCET, V2, P118

← 1 2 3 4 5 6 7 8 9 →